




Searching News Database: Santen Pharmaceutical
HSMN NewsFeed - 21 Dec 2017
Santen Receives Complete Response Letter from U.S. FDA for Intravitreal Sirolimus (DE-109)
Santen Receives Complete Response Letter from U.S. FDA for Intravitreal Sirolimus (DE-109)
Additional items found! 13

Members Archive contains
13 additional stories matching:
Santen Pharmaceutical
(Password required)
Santen Pharmaceutical
(Password required)